These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 22263416)

  • 1. [Utility of neuromuscular monitoring to diagnose neostigmine ceiling effect].
    Fabregat-López J; Ortiz-Gómez JR; Velázquez-Gil María D
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):628. PubMed ID: 22263416
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal].
    Buniatian AA; Stamov VI; Mizikov VM; Peĭkarova AV
    Anesteziol Reanimatol; 2011; (1):4-8. PubMed ID: 21513065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
    Schaller SJ; Fink H; Ulm K; Blobner M
    Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuromuscular blockade after a chain of two laparotomies in a few hours].
    Yamazaki Y; Saito A; Takahashi H
    Masui; 2011 Feb; 60(2):199-202. PubMed ID: 21384656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure.
    Herbstreit F; Zigrahn D; Ochterbeck C; Peters J; Eikermann M
    Anesthesiology; 2010 Dec; 113(6):1280-8. PubMed ID: 20980910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neostigmine-induced prolonged neuromuscular blockade in a patient with atypical pseudocholinesterase.
    Ramirez JG; Sprung J; Keegan MT; Hall BA; Bourke DL
    J Clin Anesth; 2005 May; 17(3):221-4. PubMed ID: 15896593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromuscular residual block : Unavoidable risk or reliably treatable?].
    Fuchs-Buder T
    Anaesthesist; 2019 Nov; 68(11):742-743. PubMed ID: 31705146
    [No Abstract]   [Full Text] [Related]  

  • 14. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring.
    Illman HL; Laurila P; Antila H; Meretoja OA; Alahuhta S; Olkkola KT
    Anesth Analg; 2011 Jan; 112(1):63-8. PubMed ID: 20978247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
    Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of prostigmin on the basal electromyogram in myasthenia.
    Wochnik-Dyjas D; Niewiadomska M
    Pol Med J; 1970; 9(3):730-7. PubMed ID: 4318132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erroneous attitudes in the use of neuromuscular blocking agents].
    Ortiz-Gómez JR
    Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249
    [No Abstract]   [Full Text] [Related]  

  • 18. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of neostigmine on the motor endplate in the intermediate syndrome of organophosphate poisoning].
    Besser R
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Mar; 22(1):37-9. PubMed ID: 1650695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.